Filing Flows

Filing Flows › SkinHealth Systems (SKIN) › Q2 2026

SkinHealth Systems (SKIN) Q2 2026 earnings results (second quarter 2026)

10-Q filed Aug 6, 2026

SkinHealth Systems (SKIN) reported revenue of $72.1M for the second quarter 2026 (Q2 2026), -8% from a year earlier and +11% from the quarter before. Operating margin was 5.0%, net loss $2.7M (3.7% of revenue).

Revenue$72.1M
Year over year-8%
Quarter over quarter+11%
Operating margin5.0%
Net earnings−$2.7M

SkinHealth Systems, Q2 2026: revenue $72.1M (-8% year over year), operating margin 5.0%, net loss $2.7M, operating cash flow $2.7M. The chart follows the revenue to costs, profit and cash.

Q2 2026AmountQ/QY/Y
Revenue$72.1M+11%-8%
Operating profit$3.6M——
Net earnings−$2.7M—-114%
Operating cash flow$2.7M—-72%
Free cash flow$2.2M—-77%

What changed

Revenue was $72.1M in Q2 2026, down 8% year over year and up 11% from the previous quarter. Consumables was the largest line at 75% of revenue. Delivery Systems lost $4.1M year over year (down 18%), 68% of the total change.

Gross margin was 68.4%, up 5.6 points from Q2 2025. Operating profit was $3.6M, a 5.0% margin (up 8.4 points year over year). Operating expenses fell 12% while revenue fell 8%. The fastest-growing cost line was Research & development (+12%). The quarter ended with a net loss of $2.7M, narrower than the previous quarter's $6.6M loss. Net interest and other expense of $5.0M was the main reason.

Operating cash flow was $2.7M (down 72% year over year). Non-cash charges added back $4.0M of depreciation and amortization and $2.9M of share-based compensation. Working capital and other items used $1.6M. Capital expenditures of $427K left free cash flow of $2.2M.

Questions

What was SkinHealth Systems' revenue in the second quarter 2026?

SkinHealth Systems (SKIN) reported revenue of $72.1M for the second quarter 2026 (Q2 2026), -8% from a year earlier and +11% from the quarter before.

Was SkinHealth Systems profitable in the second quarter 2026?

Operating profit was $3.6M (5.0% of revenue) and net loss $2.7M.

Open the interactive Sankey →

Source: SkinHealth Systems 10-Q on SEC EDGAR.